Transforming oncology surgery with label-free technologies
Thore Bücking and Rachel Smith from Sagentia’s Applied Science Team explore the potential role of label-free sensing in the smart surgery phenomenon. Exempt from the regulatory and clinical burdens affecting biomarkers, these technologies could unlock new possibilities for oncology surgery.
Smart surgery plays a lead role in the new era of intelligent medical technology. It provides surgeons with real-time information to improve decision-making in the operating room and offers benefits across the care continuum.
Read more of our insights
April 24, 2025
Overcoming technical barriers to blood-based diagnosis of neurodegenerative disease
February 13, 2025
Five critical factors for the commercialisation of women’s health technology
July 25, 2024
Non-invasive biomarkers: opportunities and implementation challenges for health diagnostics